Mazor Surgical Technologies enjoyed successful results at the University of Munich.
Mazor Surgical Technologies Ltd. (TASE:MZOR) share jumped 12.1% today to NIS 6.09 after the company reported a successful trial of its Guided Oblique Lumbar Interbody Fusion Solution (GO-LIF) procedure. The patent was acquired from the University of Cleveland.
The company announced that GO-LIF was used for a successful surgical procedure at the University of Munich in Germany. The surgery was performed on a 44 year-old patient with bad pains and limited movement as a result of disk problems.
Published by Globes [online], Israel business news - www.globes-online.com - on June 2, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009